The purpose of this meeting is to discuss licensing and technical topics associated with SHINE's proposed phased approach to construction and operation of its Medical Isotope Production Facility.

Purpose

Meeting Feedback

Meeting Feedback Form

Meeting Dates and Times

01/20/22, 1PM - 3PM EST

Meeting Location

Webinar

Webinar Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_MDc3NzlhNWMtODY4YS00NWYwLTk5NTAtMDJkOWU0MzYwMzVk%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%227c83c4d7-517d-4abe-ae9e-9816f13e1059%22%7d

Webinar Meeting Number: N/A

Webinar Password: N/A

Contact

Michael Balazik

(301) 415-2856

Molly-Kate Gavello

(301) 415-0293

Participation Level

Partially Closed

NRC Participants

Office of Nuclear Reactor Regulation

External Participants

SHINE Medical Technologies

Docket Numbers - Facility Names

05000608 - SHINE Medical Technologies, Inc.

Public Meeting Schedule: Meeting Details